第一作者机构:[1]Cent S Univ, Hunan Canc Hosp, Affiliated Canc Hosp, Xiangya Sch Med, Changsha, Hunan, Peoples R China[2]Geneplus Beijing Inst, Beijing, Peoples R China[3]Tumor Hosp Xinjiang Autonomous Reg, Urumqi, Peoples R China[4]Beijing Canc Hosp, Beijing, Peoples R China[5]Jiangsu Prov Hosp, Nanjing, Jiangsu, Peoples R China[6]Sun Yat Sen Univ, Canc Ctr, Guangzhou, Guangdong, Peoples R China[7]Fujian Med Univ, Canc Hosp, Fujian Canc Hosp, Fuzhou, Fujian, Peoples R China[8]Nanjing Med Univ, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China[9]Chongqing Med Univ, Affiliated Hosp 1, Dept Gen Surg, Chongqing, Peoples R China[10]Cent S Univ, Xiangya Hosp, Changsha, Hunan, Peoples R China[11]Cent S Univ, Xiangya Hosp 2, Changsha, Hunan, Peoples R China[12]Zhejiang Rongjun Hosp, Jiaxing, Peoples R China[13]Nanjing Univ, Nanjing Drum Tower Hosp, Affiliated Hosp, Med Sch, Nanjing, Jiangsu, Peoples R China[14]Weill Cornell Sch Med, Houston Methodist Res Inst, Houston, TX USA
推荐引用方式(GB/T 7714):
Han Yaqian,Xu Ying,Liu Chunling,et al.MET amplification and exon 14 skipping in treatment naive patients in lung cancer.[J].JOURNAL OF CLINICAL ONCOLOGY.2019,37(15):doi:10.1200/JCO.2019.37.15_suppl.e14543.
APA:
Han, Yaqian,Xu, Ying,Liu, Chunling,Zhao, Jun,Zhu, Lingjun...&Xia, Xuefeng.(2019).MET amplification and exon 14 skipping in treatment naive patients in lung cancer..JOURNAL OF CLINICAL ONCOLOGY,37,(15)
MLA:
Han, Yaqian,et al."MET amplification and exon 14 skipping in treatment naive patients in lung cancer.".JOURNAL OF CLINICAL ONCOLOGY 37..15(2019)